Abstract
Renin-angiotensin system inhibitor and calcium channel blocker (CCB) are widely used in controlling blood pressure (BP) in patients with chronic kidney disease (CKD). We carried out a meta-analysis to compare the renoprotective effect of the combination of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) and CCB (i.e., ACEI/ARB + CCB) with ACEI/ARB monotherapy in patients with hypertension and CKD. Publications were identified from PubMed, Embase, Medline, and Cochrane databases. Only randomized controlled trials (RCTs) of BP lowering treatment for patients with hypertension and CKD were considered. The outcomes of end-stage renal disease (ESRD), cardiovascular events, BP, urinary protein measures, estimated glomerular filtration rate (GFR), and adverse events were extracted. Based on seven RCTs with 628 patients, ACEI/ARB + CCB did not show additional benefit for the incidence of ESRD (risk ratio [RR] = 0.84; 95% confidence interval [CI]: 0.52-1.33) and cardiovascular events (RR = 0.58; 95% CI: 0.21-1.63) significantly, compared with ACEI/ARB monotherapy. There were no significant differences in change from baseline to the end points in diastolic BP (weighted mean difference [WMD] = -1.28 mm...Continue Reading
References
Mar 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F LocatelliA Giangrande
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Oct 10, 1998·Kidney International·G L BakrisF G McMahon
May 7, 1999·Kidney International·K A GriffinA K Bidani
Aug 11, 2000·The American Journal of Medicine·B F CulletonD Levy
Oct 30, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·H HerlitzM Aurell
Oct 31, 2001·Lancet·J A StaessenL Thijs
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Mar 16, 2005·Lancet·Piero RuggenentiUNKNOWN REIN-2 Study Group
Jul 15, 2005·Nephron. Clinical Practice·Mark S MacGregorJ Michael Boulton-Jones
Jan 10, 2006·Drugs·René R Wenzel
Jun 21, 2006·Psychological Methods·Tania B Huedo-MedinaJuan Botella
Oct 28, 2008·Current Cardiology Reports·Karen A Griffin, Anil K Bidani
Jan 1, 2008·Vascular Health and Risk Management·Jean-Jacques Mourad
Jul 22, 2009·PLoS Medicine·Alessandro LiberatiDavid Moher
Oct 7, 2009·Thérapie·Pierre Boutouyrie
May 1, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Mahmut Ilker YilmazLuis Miguel Blanco-Colio
Jul 29, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Naoki NakagawaUNKNOWN NICE-Combi Study Group
Sep 21, 2011·Hypertension·Piero RuggenentiUNKNOWN DEMAND Study Investigators
Dec 20, 2013·JAMA : the Journal of the American Medical Association·Paul A JamesEduardo Ortiz
Citations
Jan 23, 2017·Molecular Aspects of Medicine·Carlos OyarzúnRody San Martín
Dec 1, 2017·BMC Nephrology·Phisitt VejakamaAmmarin Thakkinstian
Oct 21, 2017·Chinese Medical Journal·Ying ZhengXiang-Mei Chen
Oct 17, 2018·International Urology and Nephrology·Punnaka PongpanichPaweena Susantitaphong
Sep 4, 2021·World Journal of Pediatrics : WJP·Farahnak Assadi